Clinical Trial

A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a randomized, double-blind phase I clinical trial to evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of AK152 in Healthy Volunteers and Patients with Alzheimer' s Disease.
Trial Details
NCT Number NCT07301502
Lead Sponsor Akeso
Conditions Alzheimer' s Disease
Enrollment 108 participants
Start Date 2025-12
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-12-24